These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism. Zhong N Mol Genet Metab; 2000; 71(1-2):195-206. PubMed ID: 11001811 [TBL] [Abstract][Full Text] [Related]
24. Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog. Hirz M; Drögemüller M; Schänzer A; Jagannathan V; Dietschi E; Goebel HH; Hecht W; Laubner S; Schmidt MJ; Steffen F; Hilbe M; Köhler K; Drögemüller C; Herden C Mol Genet Metab; 2017 Mar; 120(3):269-277. PubMed ID: 28024876 [TBL] [Abstract][Full Text] [Related]
25. Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses. Uusi-Rauva K; Blom T; von Schantz-Fant C; Blom T; Jalanko A; Kyttälä A Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468312 [TBL] [Abstract][Full Text] [Related]
26. Advances in the Treatment of Neuronal Ceroid Lipofuscinosis. Rosenberg JB; Chen A; Kaminsky SM; Crystal RG; Sondhi D Expert Opin Orphan Drugs; 2019; 7(11):473-500. PubMed ID: 33365208 [TBL] [Abstract][Full Text] [Related]
27. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses. Kida E; Golabek AA; Wisniewski KE Adv Genet; 2001; 45():35-68. PubMed ID: 11332776 [TBL] [Abstract][Full Text] [Related]
28. Batten disease: four genes and still counting. Mole SE Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573 [TBL] [Abstract][Full Text] [Related]
29. Pathomechanisms in the neuronal ceroid lipofuscinoses. Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162 [TBL] [Abstract][Full Text] [Related]
30. The neuronal ceroid-lipofuscinoses: a historical introduction. Haltia M; Goebel HH Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893 [TBL] [Abstract][Full Text] [Related]
31. Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease. Simonati A; Pezzini F; Moro F; Santorelli FM Curr Mol Med; 2014 Oct; 14(8):1043-1051. PubMed ID: 25323868 [TBL] [Abstract][Full Text] [Related]
32. Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses. Morsy A; Carmona AV; Trippier PC Molecules; 2021 Oct; 26(20):. PubMed ID: 34684815 [TBL] [Abstract][Full Text] [Related]
33. Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses. Bartsch U; Storch S Front Neurol; 2022; 13():866983. PubMed ID: 35509995 [TBL] [Abstract][Full Text] [Related]
34. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Mole SE; Williams RE; Goebel HH Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709 [TBL] [Abstract][Full Text] [Related]
35. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Mole SE Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939 [TBL] [Abstract][Full Text] [Related]